
Vogmeri MF G 2mg/500mg/0.3mg Tablet
Manufacturer
Merlyn Biotech
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Key Information
Short Description
Vogmeri MF G 2mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Dosage Form
Tablet
Introduction
Vogmeri MF G 2mg/500mg/0.3mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor.Swallow it as a whole. Do not chew, crush or break it.Vogmeri MF G 2mg/500mg/0.3mg Tablet is to be taken empty stomach
How it works
Vogmeri MF G 2mg/500mg/0.3mg Tablet is a combination of three antidiabetic medicines
Quick Tips
Take it with food to lower your chance of having an upset stomach Carry a sugar source with you for immediate relief Your doctor may check your liver function regularly Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice)
Related Medicines

Glimpure MV 2.3 Tablet

Voglimust MF 2mg/500mg/0.3mg Tablet

Zuriglim MV 2mg/500mg/0.3mg Tablet

Glimijoy MV 2mg/500mg/0.3mg Tablet

Glimerin V 2mg/500mg/0.3mg Tablet

Volicure Trio 2mg/500mg/0.3mg Tablet

Yesglim Trio 2mg/500mg/0.3mg Tablet

Voglisoor GM 2mg/500mg/0.3mg Tablet

Ecovog GM 2mg/500mg/0.3mg Tablet

Vogligem GM 2mg/500mg/0.3mg Tablet
Frequently asked questions
What is Vogmeri MF G 2mg/500mg/0.3mg Tablet?
Vogmeri MF G 2mg/500mg/0.3mg Tablet is a combination medication that contains three active ingredients: Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride helps increase insulin production in the pancreas, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose levels. This medication is not suitable for treating type 1 DM.
What are the possible side effects of Vogmeri MF G 2mg/500mg/0.3mg Tablet?
Common side effects of Vogmeri MF G 2mg/500mg/0.3mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor for guidance.
Are there any specific conditions in which Vogmeri MF G 2mg/500mg/0.3mg Tablet should not be taken?
Vogmeri MF G 2mg/500mg/0.3mg Tablet should be avoided in patients with known allergies to its components or excipients. Additionally, it is contraindicated in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Vogmeri MF G 2mg/500mg/0.3mg Tablet?
No, it is not recommended to consume alcohol while taking Vogmeri MF G 2mg/500mg/0.3mg Tablet. This combination may increase the risk of hypoglycemia and lactic acidosis. Consult your doctor for personalized advice on medication and alcohol use.
Can the use of Vogmeri MF G 2mg/500mg/0.3mg Tablet cause hypoglycemia?
Yes, Vogmeri MF G 2mg/500mg/0.3mg Tablet can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and keep glucose tablets, honey, or fruit juice nearby.
What are the instructions for the storage and disposal of Vogmeri MF G 2mg/500mg/0.3mg Tablet?
Store Vogmeri MF G 2mg/500mg/0.3mg Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.